Brightstar Therapeutics
PrivateLast Round
Series A
Apr 18, 2023
Company Overview
Brightstar Therapeutics is a biotechnology company that provides innovative treatment options for people living with corneal and ocular surface diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brightstar Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Brightstar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 18, 2023 |
Key People
Founding team and executive leadership
Brightstar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Discovery Capital Funding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
Introduced BrightMEM, a long-term corneal allograft solution.
Brightstar Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brightstar Therapeutics's valuation, stock price, and market status.
